We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Optical Sensor to Detect Vitamin B12 Deficiency

By LabMedica International staff writers
Posted on 26 Oct 2016
Researchers have developed the first optical sensor that can detect vitamin B12 in diluted human blood – and a first step towards a low-cost, portable, broadscale B12 deficiency test that would overcome limitations of current methods for monitoring levels in high-risk individuals and populations.

The device, developed by scientists at the University of Adelaide (Adelaide, Australia), was presented October 17, 2016, at the inaugural “SPIE BioPhotonics Australasia” international conference in Adelaide.

Image: Dr. Georgios Tsiminis in his photonics laboratory (Photo courtesy of the University of Adelaide).
Image: Dr. Georgios Tsiminis in his photonics laboratory (Photo courtesy of the University of Adelaide).

“Vitamin B12 deficiency has been shown to be a potential modifiable risk factor for dementia and Alzheimer’s disease and is associated with cognitive decline,” said Dr. Georgios Tsiminis, research fellow at the University of Adelaide, “Older adults are particularly at risk of B12 deficiency due to age-related reduction in absorbing vitamin B12 received through their diet.

Currently at proof-of-concept stage, the sensor demonstrates feasibility of testing for vitamin B12 in human blood serum without the need for a full laboratory test. It could provide point-of-care B12 tracking in, for example, healthy ageing adults, enabling early treatment intervention as soon as deficiency is detected.

“This is the first time a rapid technique based on optical spectroscopy has been shown to be able to detect vitamin B12 in human blood serum. We believe this is a very promising first step towards achieving this goal,” said Dr. Tsiminis.

Currently, routine B12 testing is not being carried out due to time and cost limitations. “Our method provides a realistic basis for a system that is portable, cost-effective, and affords rapid results, along the lines of the pin-prick test for diabetes,” said Dr. Tsiminis. The device uses Raman spectroscopy to produce the vitamin B12 optical fingerprint, takes under 1 minute to measure B12 in human blood, and requires minimal preparation.

Related Links:
University of Adelaide


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Electrolyte Analyzer
BKE-B
Multi-Chamber Washer-Disinfector
WD 390

Latest Technology News

National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
26 Oct 2016  |   Technology

AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
26 Oct 2016  |   Technology

Agentic AI Platform Supports Genomic Decision-Making in Oncology
26 Oct 2016  |   Technology



PURITAN MEDICAL